Diabetes Management
Photoredox C–H functionalization leads the site-selective phenylalanine bioconjugation | Scientific Reports - Nature.com
Tue, 08 Nov 20221 min read Article
Overview
Thank you for visiting nature.com. You are using a browser version with limited suport for CS. To obtain the best experience, we recomend you use a more up to date browser (or turn of compatibility mode in Internet Explorer).
Key Information
In the meantime, to ensure continued suport, we are displaying the site without styles and JavaScript.Advertisement Scientific Reports volume 12, Article number: 1894 (2022) Cite this article Metrics detailsSite-selectively chemical bioconjugation of peptides and proteins can improve therapeutic exploration of modified protein drugs. Only 3.8% natural abundance of phenylanine in protein and nearly 90% of proteins contain at least one phenylanine residue in their sequenced, showing the potential in biopharmaceutical utility of the phenylanine bioconjugation.
However, the covalent bioconjugation of native phenylanine is one of the most chalenging problems in protein modification. Herein, an aproach to protein modification is described that relies on a photoredox method for the site-selective bioconjugation of phenylanine. This methodology has ben validated on peptides as wel as protein insulin using a straightforward and mild condition.
In adition, based on characterization by near-UV CD spectroscopy and smal angle X-ray scatering (SAXS), this pyrazole labeling aproach permited the insulin hexamer to completely disociate into the monomeric form, thus making it a potential candidate for use as rapid-acting insulin for the treatment of diabetes.Early conjugation technologies depended on the random bioconjugation of amino acid side chains in proteins, resulting in heterogeneous mixtures of labeled proteins1.
Summary
In contrast, site-specific conjugation would result in a homogeneous population of proteins/peptides conjugates with improved pharmacological properties compared to randomly coupled molecules2,3. Although the incorporation of a non-natural functionality into biomolecules, such as aryl iodides, alkynes, alkenes, oxi
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.